Share this!

We are pleased to announce the acquisition of Brand Aid Digital! Brand Aid joins Gold Group’s award winning GoMo Health division with a focus on patient engagement, acquisition and retention.

Activating Advancement of Clinical Trials Research via the GoMo Engagement Platform

The merger of these patient-centered partners enables the Brand Aid team to leverage the GoMo patient engagement mobile web platform for key services including clinical trial investigator and patient recruitment, retention and real-time data collection to drive population health management and care coordination.

The GoMo platform is the manifestation of GoMo Health’s proprietary BehavioralRx™, the cognitive and behavioral science of patient engagement. Click here to learn more about the GoMo platform.

The combined team will provide:

  • Patient engagement solutions that can help clients communicate more effectively.
  • A dedicated marketing and technology team that is experienced in the pharmaceutical industry.
  • Expanded mobile web capabilities to support patient recruitment and retention.
  • Global capabilities and reach.

“We are excited about aligning our business with GoMo Health and their unique Behavioral Rx™ science and methodologies. We see a proven path forward being used by millions of patients that can change the way healthcare is delivered to empower patients,” says Elaine Oussoren, President of Brand Aid.

Robert Gold, CEO of Gold Group commented, “Brand Aid’s highly experienced pharma team and their digital expertise will help to expand our offering to a broader audience in the healthcare continuum. We are excited to have them join us as we see our offering gain traction, acceptance and ROI among providers and payers.”

Share this!